Correction: Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia

This article was originally published under an incorrect license. This has now been amended and is available under a CC BY-NC-ND 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.

• Publication year

  2018

• Venue

  European Journal of Human Genetics

• Publication date

  2018-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41431-018-0186-3PMID 29980747PMCID PMC6117290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How is genetic testing evaluated? A systematic review of the literature

  2018cited by this paper
• Personal utility in genomic testing: a systematic literature review

  2017cited by this paper
• Utility of thrombophilia testing in patients with venous thrombo-embolism.

  2016cited by this paper
• Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

  2016cited by this paper
• Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations

  2016cited by this paper
• Current state of genomic policies in healthcare among EU member states: results of a survey of chief medical officers

  2016cited by this paper
• A qualitative study of patients’ perceptions of the value of molecular diagnosis for familial hypercholesterolemia (FH)

  2016cited by this paper
• Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30

  2016cited by this paper
• Genetic testing and economic evaluations: a systematic review of the literature.

  2015cited by this paper
• Delivering value by focusing on patient experience.

  2015cited by this paper
• Examining the Role of Patient Experience Surveys in Measuring Health Care Quality

  2014cited by this paper
• Clinical Utility Gene Card for: Familial adenomatous polyposis (FAP) and attenuated FAP (AFAP) - update 2014

  2014cited by this paper
• Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy

  2013cited by this paper
• Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study

  2013cited by this paper
• Knowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancer.

  2013cited by this paper
• VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.

  2011cited by this paper
• Measuring the effects of genetic testing: studies on thrombophilia, sickle cell trait, recurrent miscarriage and male subfertility

  2011cited by this paper
• Evaluation of the validity and utility of genetic testing for rare diseases.

  2010cited by this paper
• The relationship between patients' perception of care and measures of hospital quality and safety.

  2010cited by this paper
• Psychological distress and use of psychosocial support in familial adenomatous polyposis

  2010cited by this paper
• Patient satisfaction and cancer‐related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2

  2010cited by this paper
• Disclosing the Disclosure: Factors Associated With Communicating the Results of Genetic Susceptibility Testing for Alzheimer's Disease

  2009cited by this paper
• How does satisfaction with the health-care system relate to patient experience?

  2009cited by this paper
• Does thrombophilia testing help in the clinical management of patients?

  2008cited by this paper
• Purposeful selection of variables in logistic regression

  2008cited by this paper
• Benefit Finding in Response to BRCA1/2 Testing

  2008cited by this paper
• Convergence Failures in Logistic Regression

  2008cited by this paper
• Outcome measurement in clinical genetics services: a systematic review of validated measures.

  2008cited by this paper
• Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up

  2007cited by this paper
• What is the clinical utility of genetic testing?

  2006cited by this paper
• Testing for thrombophilia: an evidence-based approach

  2006cited by this paper
• Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia.

  2006cited by this paper
• Toward a biopsychosocial model for 21st-century genetics.

  2005cited by this paper
• Psychological impact of genetic testing for cancer susceptibility: an update of the literature

  2005cited by this paper
• Genetic testing for hereditary colorectal cancer in children: Long‐term psychological effects

  2003cited by this paper
• The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties.

  1998cited by this paper

• Evaluation of Predictive Genomic Applications

  2020cites this paper
• Quality of life drives patients’ preferences for secondary findings from genomic sequencing

  2020cites this paper
• Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene “Mutation” (G20210A)

  2019cites this paper
• Тромботическая микроангиопатия у онкологических больных Thrombotic Microangiopathy in Cancer Patients

  2019cites this paper
• Vestnik 5-2019 COLOR.indd

  2019cites this paper
• Genetic and Molecular Testing in Thrombosis and Hemostasis: Informing Surveillance, Treatment, and Prognosis

  2019cites this paper
• The Evolution of Public Health Genomics: Exploring Its Past, Present, and Future

  2018cites this paper
• CGH analysis in Colombian patients: findings of 1374 arrays in a seven-year study

  2018cites this paper